These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6327334)

  • 1. Strain differences in the hyperalgesic effect of a novel kappa receptor agonist, U-50488H in mice.
    Ramabadran K
    Eur J Pharmacol; 1984 Mar; 98(3-4):425-7. PubMed ID: 6327334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperalgesic effect of the selective kappa opioid agonist, U-50488H in mice.
    Ramabadran K
    Jpn J Pharmacol; 1983 Dec; 33(6):1289-92. PubMed ID: 6321836
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical and functional interactions of a selective kappa opioid agonist with calcium.
    VonVoigtlander PF; Ochoa MC; Lewis RA
    Adv Exp Med Biol; 1987; 221():345-55. PubMed ID: 2829584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis and cholera toxins modulate kappa-opioid receptor agonists-induced hypothermia and gut inhibition.
    Shukla VK; Turndorf H; Bansinath M
    Eur J Pharmacol; 1995 Mar; 292(3-4):293-9. PubMed ID: 7796869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid.
    Vonvoigtlander PF; Lewis RA
    J Pharmacol Exp Ther; 1988 Jul; 246(1):259-62. PubMed ID: 2839665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of the kappa opioid receptor agonist U-50488H in experimental acute brain and spinal cord injury.
    Hall ED; Wolf DL; Althaus JS; Von Voigtlander PF
    Brain Res; 1987 Dec; 435(1-2):174-80. PubMed ID: 2827851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
    Parsons CG; West DC; Headley PM
    NIDA Res Monogr; 1986; 75():461-4. PubMed ID: 2828992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa-opiate agonist-induced inhibition of gastrointestinal transit in different strains of mice.
    Bansinath M; Ramabadran K; Turndorf H; Puig MM
    Pharmacology; 1991; 42(2):97-102. PubMed ID: 1648236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective enhancement of nociception by opioids in different strains of mice.
    Ramabadran K
    Jpn J Pharmacol; 1985 Mar; 37(3):296-9. PubMed ID: 2987591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal analgesic actions of kappa receptor agonists, U-50488H and spiradoline (U-62066).
    Piercey MF; Einspahr FJ
    J Pharmacol Exp Ther; 1989 Oct; 251(1):267-71. PubMed ID: 2552077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the anticonvulsant U-54494A on cortical neuron excitability: comparison to the kappa agonist U-50488H.
    Ochoa MC; Vogelsang GD; Lum JT; VonVoigtlander PF; Piercey MF
    Life Sci; 1992; 50(17):1225-33. PubMed ID: 1349150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic influences in opioid analgesic sensitivity in mice.
    Pick CG; Cheng J; Paul D; Pasternak GW
    Brain Res; 1991 Dec; 566(1-2):295-8. PubMed ID: 1667610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the selective kappa-opioid receptor agonist U-50,488 on locomotor activity and passive avoidance behaviour in DBA/2 and C57BL/6 mice.
    Castellano C; Pavone F
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):270-80. PubMed ID: 2823735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The selective kappa-opioid agonist, U-50,488H, produces antinociception in the rat via a supraspinal action.
    Czlonkowski A; Millan MJ; Herz A
    Eur J Pharmacol; 1987 Oct; 142(1):183-4. PubMed ID: 2826175
    [No Abstract]   [Full Text] [Related]  

  • 15. Kappa opioid receptor-mediated depression of activity evoked in convergent dorsal horn cells by thermal and non-thermal noxious stimulation.
    Hernández A; Paeile C; Pérez H; Pelissier T; Soto-Moyano R
    Eur J Pharmacol; 1990 Sep; 186(2-3):323-5. PubMed ID: 1963150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebroventricular administration of kappa-agonists induces convulsions in mice.
    Bansinath M; Ramabadran K; Turndorf H; Shukla VK
    Brain Res Bull; 1991 Jul; 27(1):75-9. PubMed ID: 1657321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tonic pain perception in the mouse: differential modulation by three receptor-selective opioid agonists.
    Murray CW; Cowan A
    J Pharmacol Exp Ther; 1991 Apr; 257(1):335-41. PubMed ID: 1850470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kappa-opioid peptide receptor stimulation increases cytosolic pH and myofilament responsiveness to Ca2+ in cardiac myocytes.
    Ventura C; Capogrossi MC; Spurgeon HA; Lakatta EG
    Am J Physiol; 1991 Nov; 261(5 Pt 2):H1671-4. PubMed ID: 1659231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of endogenous opioid mechanism in the production of the antinociceptive effect induced by psychological stress in mice.
    Takahashi M; Tokuyama S; Kaneto H
    Jpn J Pharmacol; 1987 Jul; 44(3):283-91. PubMed ID: 2821308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereospecific inhibition of gastrointestinal transit by kappa opioid agonists in mice.
    Ramabadran K; Bansinath M; Turndorf H; Puig MM
    Eur J Pharmacol; 1988 Oct; 155(3):329-31. PubMed ID: 2853069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.